These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm. Brady MJ, Thomas J, Wong TZ, Franklin KM, Ho LM, Paulson EK. Radiology; 2009 Feb; 250(2):523-30. PubMed ID: 19188319 [Abstract] [Full Text] [Related]
6. PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. Boland GW, Blake MA, Holalkere NS, Hahn PF. AJR Am J Roentgenol; 2009 Apr; 192(4):956-62. PubMed ID: 19304700 [Abstract] [Full Text] [Related]
7. Incidental non-secreting adrenal masses in cancer patients: intra-individual comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography with computed tomography and shift magnetic resonance imaging. Gratz S, Kemke B, Kaiser W, Heinis J, Behr TM, Höffken H. J Int Med Res; 2010 Apr; 38(2):633-44. PubMed ID: 20515577 [Abstract] [Full Text] [Related]
11. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions. Ozcan Kara P, Kara T, Kara Gedik G, Kara F, Sahin O, Ceylan Gunay E, Sari O. Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046 [Abstract] [Full Text] [Related]
12. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT. Zytoon AA, Murakami K, El-Kholy MR, El-Shorbagy E, Ebied O. Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387 [Abstract] [Full Text] [Related]
15. Adrenal-to-liver SUV ratio is the best parameter for differentiation of adrenal metastases from adenomas using 18F-FDG PET/CT. Watanabe H, Kanematsu M, Goshima S, Kondo H, Kawada H, Noda Y, Moriyama N. Ann Nucl Med; 2013 Aug; 27(7):648-53. PubMed ID: 23625579 [Abstract] [Full Text] [Related]
16. Diagnostic performance of unenhanced computed tomography and 18 F-fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours. Delivanis DA, Bancos I, Atwell TD, Schmit GD, Eiken PW, Natt N, Erickson D, Maraka S, Young WF, Nathan MA. Clin Endocrinol (Oxf); 2018 Jan; 88(1):30-36. PubMed ID: 28815667 [Abstract] [Full Text] [Related]